Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (221-230 of 403) with videos related to

Pageof 41
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2025
Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025Helen Campbell, Jay Lucidarme, Stephen A Clark, et al.
Clinical and Vaccine Immunology : CVI|December 31, 2010
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of ageElizabeth Miller, Nick Andrews, Pauline Waight, et al.
Human Vaccines & Immunotherapeutics|October 24, 2018
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedulesAlessia Biolchi, Sara Tomei, Laura Santini, et al.
The Journal of Infection|December 3, 2021
Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccinationClarissa Oeser, Heather Whitaker, Ezra Linley, et al.
Vaccine|May 27, 2019
Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM<sub>197</sub>-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trialMohamed Tashani, Al-Mamoon Badahdah, Mohammad Alfelali, et al.
Vaccine|August 20, 2013
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverageGiacomo Frosi, Alessia Biolchi, Morena Lo Sapio, et al.
Human Vaccines & Immunotherapeutics|July 8, 2024
4CMenB journey to the 10-year anniversary and beyondVéronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlersDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
Vaccine|July 11, 2016
Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell diseaseAlessandra R Souza, Claudia M Maruyama, Marco Aurélio P Sáfadi, et al.
Vaccine|October 28, 2020
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testingMarta Valente Pinto, Kimberly Davis, Nick Andrews, et al.
Pageof 41

Showing results (221-230 of 403) with videos related to

Sort By:
Pageof 41
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2025
Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025Helen Campbell, Jay Lucidarme, Stephen A Clark, et al.
Clinical and Vaccine Immunology : CVI|December 31, 2010
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of ageElizabeth Miller, Nick Andrews, Pauline Waight, et al.
Human Vaccines & Immunotherapeutics|October 24, 2018
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedulesAlessia Biolchi, Sara Tomei, Laura Santini, et al.
The Journal of Infection|December 3, 2021
Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccinationClarissa Oeser, Heather Whitaker, Ezra Linley, et al.
Vaccine|May 27, 2019
Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM<sub>197</sub>-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trialMohamed Tashani, Al-Mamoon Badahdah, Mohammad Alfelali, et al.
Vaccine|August 20, 2013
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverageGiacomo Frosi, Alessia Biolchi, Morena Lo Sapio, et al.
Human Vaccines & Immunotherapeutics|July 8, 2024
4CMenB journey to the 10-year anniversary and beyondVéronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlersDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
Vaccine|July 11, 2016
Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell diseaseAlessandra R Souza, Claudia M Maruyama, Marco Aurélio P Sáfadi, et al.
Vaccine|October 28, 2020
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testingMarta Valente Pinto, Kimberly Davis, Nick Andrews, et al.
Pageof 41